Ellevest Inc’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-33
Closed -$1.88K 1975
2022
Q4
$1.88K Hold
33
﹤0.01% 1403
2022
Q3
$1K Sell
33
-42
-56% -$1.86K ﹤0.01% 1464
2022
Q2
$3K Buy
75
+13
+21% +$562 ﹤0.01% 1097
2022
Q1
$2K Hold
62
﹤0.01% 1191
2021
Q4
$2K Sell
62
-81
-57% -$3.02K ﹤0.01% 1163
2021
Q3
$6K Sell
143
-49
-26% -$2.05K ﹤0.01% 923
2021
Q2
$9K Sell
192
-33
-15% -$1.46K ﹤0.01% 784
2021
Q1
$9K Buy
225
+60
+36% +$2.74K ﹤0.01% 796
2020
Q4
$7K Buy
165
+87
+112% +$3.13K ﹤0.01% 788
2020
Q3
$2K Buy
78
+40
+105% +$1.11K ﹤0.01% 902
2020
Q2
$1K Sell
38
-54
-59% -$1.22K ﹤0.01% 1005
2020
Q1
$2K Buy
92
+14
+18% +$266 ﹤0.01% 771
2019
Q4
$1K Buy
+78
New +$1.35K ﹤0.01% 780

Other funds holding HALO

Ellevest Inc's HALO Position: Q1 2023 in Review

Ellevest Inc sold out of Halozyme (HALO) in Q1 2023, closing a stake of 33 shares — an estimated $1.88K sold.

Ellevest Inc first reported a position in HALO in Q4 2019 and held it in 13 quarters. The position peaked at $9K in Q2 2021. 386 funds tracked by Wall St. Rank hold HALO as of Q1 2023.

  • Ellevest Inc reported no remaining Halozyme position as of Q1 2023 after selling out during the quarter.
  • Ellevest Inc sold 33 Halozyme shares in Q1 2023, an estimated $1.88K.
  • Ellevest Inc first reported a position in Halozyme in Q4 2019 and held it in 13 quarters.
  • Ellevest Inc's Halozyme position peaked at $9K in Q2 2021.
  • 386 funds tracked by Wall St. Rank held Halozyme as of Q1 2023.

Based on Ellevest Inc's 13F filing for Q1 2023, filed 4 May 2023.